Mucoepidermoid carcinoma of the parotid gland - The Mayo Clinic experience

被引:77
作者
Boahene, DKO
Olsen, KD
Lewis, JE
Pinheiro, AD
Pankratz, VS
Bagniewski, SM
机构
[1] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA
[4] Mayo Clin, Div Biostat, Rochester, MN 55905 USA
[5] Greater Baltimore Head & Neck Associates, Baltimore, MD USA
关键词
D O I
10.1001/archotol.130.7.849
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To determine clinical and histopathologic features of mucoepidermoid carcinoma of the parotid gland, specifically, the relation of tumor stage and grade and treatment type with clinical outcome. Design:Retrospective clinical and histopathologic review. Setting: Tertiary care medical center. Patients: From 1940 to 1904, 128 patients were treated at our institution for parotid mucoepidermoid carcinoma. Eighty-nine of these patients had their first treatment at our institution; these cases were chosen for retrospective clinical, and histopathologic review. Intervention: A head and neck pathologist independently reviewed the pathology specimens. Main Outcome Measures: Age, symptoms, stage, treatment type, tumor grade, pathological features, disease progression, and survival. Results: Results of clinical staging were: T1 in 56 patients, T2 in 13, T3 in 1, T4 in 15, NO in 85, N 1 in 2, and N2 in 2. No patient had N3 or M1 disease. All patients underwent parotidectomy with or without neck dissection. Seven patients received postoperative radiotherapy. Tumor grade was low in 43 patients (48%), intermediate in 40 (45%), and high in 6 (7%). Only 5 patients had disease progression (local recurrence in 4, regional recurrence in 4, and distant recurrence in 2). At latest follow-up (mean follow-up, 14.7 years), 64 patients were alive without disease, I was alive with disease, 2 had died of mucoepidermoid carcinoma, and 22 had died of other causes. The Kaplan-Meier estimated cancer-specific survival rates at 5, 15, and 25 years were 98.8%, 97.4%, and 97.4%, respectively. Conclusions: In our study, tumor grade and stage appeared to be less important than previously described. With adequate parotidectomy and appropriate neck dissection, patients with mucoepidermoid carcinoma of the parotid gland appear to do well, with few recurrences.
引用
收藏
页码:849 / 856
页数:8
相关论文
共 34 条
[1]  
ACCETTA PA, 1984, ARCH PATHOL LAB MED, V108, P321
[2]   SALIVARY-GLAND NEOPLASIA - OUTCOME OF MODIFIED MORPHOGENESIS AND CYTODIFFERENTIATION [J].
BATSAKIS, JG .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1980, 49 (03) :229-232
[3]   STAGING OF SALIVARY-GLAND NEOPLASMS - ROLE OF HISTOPATHOLOGIC AND MOLECULAR FACTORS [J].
BATSAKIS, JG .
AMERICAN JOURNAL OF SURGERY, 1994, 168 (05) :386-390
[4]   Mucoepidermoid carcinoma - A clinicopathologic study of 80 patients with special reference to histological grading [J].
Brandwein, MS ;
Ivanov, K ;
Wallace, DI ;
Hille, JJ ;
Wang, B ;
Fahmy, A ;
Bodian, C ;
Urken, ML ;
Gnepp, DR ;
Huvos, A ;
Lumerman, H ;
Mills, SE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (07) :835-845
[5]  
CALIFANO L, 1993, INT SURG, V78, P347
[6]   MUCOEPIDERMOID CARCINOMA OF THE SALIVARY-GLANDS - A REAPPRAISAL OF THE INFLUENCE OF TUMOR DIFFERENTIATION ON PROGNOSIS [J].
CLODE, AL ;
FONSECA, I ;
SANTOS, JR ;
SOARES, J .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (02) :100-106
[7]  
Cornog JL, 1976, DIS SALIVARY GLANDS, P99
[9]  
FOOTE FW, 1953, CANCER, V6, P1065, DOI 10.1002/1097-0142(195311)6:6<1065::AID-CNCR2820060602>3.0.CO
[10]  
2-0